These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36156183)

  • 1. Telehealth Interventions for HIV in Low- and Middle-Income Countries.
    Phan JM; Kim S; Linh ĐTT; Cosimi LA; Pollack TM
    Curr HIV/AIDS Rep; 2022 Dec; 19(6):600-609. PubMed ID: 36156183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP).
    Touger R; Wood BR
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):113-119. PubMed ID: 30701404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
    Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: PrEPTECH: A Telehealth-Based Initiation Program for HIV Pre-exposure Prophylaxis in Young Men of Color Who Have Sex With Men. A Pilot Study of Feasibility.
    Refugio ON; Kimble MM; Silva CL; Lykens JE; Bannister C; Klausner JD
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):40-45. PubMed ID: 30272632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of telehealth services in the healthcare system: with emphasis on the experience of patients living with HIV.
    Dandachi D; Lee C; Morgan RO; Tavakoli-Tabasi S; Giordano TP; Rodriguez-Barradas MC
    J Investig Med; 2019 Jun; 67(5):815-820. PubMed ID: 30826803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of HIV in Low- and Middle-Income Countries (LMICs).
    Kityo C; Cortes CP; Phanuphak N; Grinsztejn B; Venter F
    Clin Infect Dis; 2022 Nov; 75(Suppl 4):S549-S556. PubMed ID: 36410377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings--a systematic review.
    Govindasamy D; Meghij J; Kebede Negussi E; Clare Baggaley R; Ford N; Kranzer K
    J Int AIDS Soc; 2014; 17(1):19032. PubMed ID: 25095831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV drug resistance in low-income and middle-income countries.
    Hamers RL; Rinke de Wit TF; Holmes CB
    Lancet HIV; 2018 Oct; 5(10):e588-e596. PubMed ID: 30193863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions to increase the uptake and continuation of pre-exposure prophylaxis (PrEP) by adolescent girls and young women at high risk of HIV in low-income and middle-income countries: a scoping review.
    Ekwunife OI; Ejie IL; Okelu V; Mita C; Durosinmi-Eti O; Powell A; Franke MF
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36593640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Project ECHO: telementoring to educate and support prescribing of HIV pre-exposure prophylaxis by community medical providers.
    Wood BR; Mann MS; Martinez-Paz N; Unruh KT; Annese M; Spach DH; Scott JD; Stekler JD
    Sex Health; 2018 Nov; 15(6):601-605. PubMed ID: 30318034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of Mobile Phone Interventions (SMS/IVR/Calls) to Improve Adherence and Retention to Antiretroviral Treatment in Low-and Middle-Income Countries.
    Demena BA; Artavia-Mora L; Ouedraogo D; Thiombiano BA; Wagner N
    AIDS Patient Care STDS; 2020 Feb; 34(2):59-71. PubMed ID: 32049555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a telemedicine pilot program for the provision of HIV pre-exposure prophylaxis in the Southeastern United States.
    Player MS; Cooper NA; Perkins S; Diaz VA
    AIDS Care; 2022 Dec; 34(12):1499-1505. PubMed ID: 34978217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Pre-exposure Prophylaxis Prescribing Through Telehealth.
    Stekler JD; McMahan V; Ballinger L; Viquez L; Swanson F; Stockton J; Crutsinger-Perry B; Kern D; Scott JD
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):e40-e42. PubMed ID: 29280768
    [No Abstract]   [Full Text] [Related]  

  • 14. Awareness, knowledge, and attitudes related to HIV pre-exposure prophylaxis and other prevention strategies among physicians from Brazil and Mexico: cross-sectional web-based survey.
    Vega-Ramirez H; Torres TS; Guillen-Diaz C; Pimenta C; Diaz-Sosa D; Konda KA; da Cunha ARC; Robles-Garcia R; Benedetti M; Hoagland B; Bezerra DRB; Caceres CF; Grinsztejn B; Veloso VG;
    BMC Health Serv Res; 2022 Apr; 22(1):532. PubMed ID: 35459177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-based violence and engagement in biomedical HIV prevention, care and treatment: a scoping review.
    Leddy AM; Weiss E; Yam E; Pulerwitz J
    BMC Public Health; 2019 Jul; 19(1):897. PubMed ID: 31286914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential of Telecommunication Technology to Address Racial/Ethnic Disparities in HIV PrEP Awareness, Uptake, Adherence, and Persistence in Care: A Review.
    Evans KN; Hassan R; Townes A; Buchacz K; Smith DK
    AIDS Behav; 2022 Dec; 26(12):3878-3888. PubMed ID: 35614366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-Exposure Prophylaxis (PrEP) Uptake among Black Men Who Have Sex with Men (BMSM) in the Southern U.S.
    Adeagbo O; Harrison S; Qiao S; Li X
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of telehealth to manage the Covid-19 pandemic in low- and middle-income countries: a scoping review.
    Eslami Jahromi M; Ayatollahi H
    J Am Med Inform Assoc; 2023 Mar; 30(4):738-751. PubMed ID: 36565464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing HIV Patient Support Through Telehealth: Exploring Design Solutions.
    Noll R; Voigt A; Koehler S; Mueller A; Stephan C; Carney J; Von Wagner M; Weber T; Storf H; Schaaf J
    Stud Health Technol Inform; 2023 Oct; 309():150-154. PubMed ID: 37869829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.